Evercore ISI Rates Vaxcyte Inc. (PCVX) as an Overweight Following CDC Changes to Childhood Vaccination Recommendations

Vaxcyte Inc. (NASDAQ:PCVX) is one of the champion US stocks to bargain nether $50. On January 23, Cantor Fitzgerald reaffirmed its Overweight standing connected Vaxcyte Inc. (NASDAQ:PCVX), keeping a affirmative presumption arsenic the institution advances its vaccine pipeline connected schedule. The steadfast expects topline results from the Phase 3 OPUS-1 proceedings successful precocious 2026, with an big BLA filing planned for 2027.

It besides noted advancement successful different studies: OPUS-2 has started dosing, OPUS-3 volition statesman successful aboriginal 2026, and some should study results successful 2027. Meanwhile, the babe Phase 2 VAX-31 survey is connected track, with cardinal readouts expected by mid-2027.

Earlier connected January 6, Evercore ISI reiterated an Outperform standing connected Vaxcyte Inc., impressed by the CDC’s changes to puerility vaccination recommendations.

The affirmative stance comes from the CDC removing broad recommendations for respective vaccines, including Flu, COVID-19, and Hepatitis B. In addition, recommendations for puerility vaccinations, specified arsenic measles, polio, tetanus, and HPV, among others, stay successful place.

The institution is well-positioned to benefit, arsenic it is besides processing pneumococcal conjugate vaccines (PCVs). That’s due to the fact that vaccine-sceptic groups and the CDC person yet to people pneumococcal vaccines.

Meanwhile, Jefferies maintains a Buy standing connected the banal with a $146 terms target. The probe steadfast has echoed the company’s prospects amid the Phase 3 VAX-31 big trial. Designed to support against 31 types of Streptococcus pneumonia, VAX 31 has already delivered topline results successful Phase ½ objective trials.

Vaxcyte Inc. (NASDAQ:PCVX) has already met non-inferiority and superiority endpoints successful the trials, frankincense connected people to go the caller modular for big pneumococcal vaccination and consolidate marketplace stock against competing vaccines.

While we admit the imaginable of PCVX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Top 10 Materials Stocks to Buy According to Analysts and 10 Best Organic Food and Farming Stocks to Buy Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.